Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
ESMO 2022
🚨 24 hours until #ESMOAsia23 🚨
Make sure to stay tuned for the congress – follow us @VJOncology and head to http://VJOncology.com for exciting developments
@myESMO #Oncology #ImmunoOnc
🎥Jolanta Kunikowska of @UniWarszawski discusses the importance of genotype in accurate diagnosis and treatment of paragangliomas/pheochromocytomas:
➡️⬅️
@myESMO #ESMO23 #hncSM
The importance of genotype in accurate diagnosis and treatment of paragangliomas/ pheochromocytomas
Jolanta Kunikowska, MD, PhD, Medical University of Warsaw, Warsaw, Poland, discusses the observation of genotype in th...
ow.ly
November is #LungCancer Awareness month 🫁 📣
Check out this NEW VJSessions episode: #CTscreening for patients with #lungcancer in the UK with @BTOGORG 💬 🇬🇧
With David Baldwin, Beth Sage, Phillip Crosbie, Matthew Callister and Arjun Nair ⬇️
https://ow.ly/yozx50Q5n7H
#LCsm
🎥@RobinL_Jones from @ICR_London shares his highlights in sarcoma from #ESMO23:
➡️⬅️
@myESMO #scmSM
Highlights in sarcoma at ESMO 2023
Robin L. Jones, MBBS, MRCP, MD, Institute of Cancer Research in London, highlights key sessions in sarcoma at the ...
ow.ly
🎥@BenWestphalen of @LMU_Muenchen highlights the transformative impact of KRAS inhibitors, like sotorasib and panitumumab, across oncology, with significant advancements discussed at #ESMO23:
➡️⬅️
#PancSM #CRCSM #ImmunoOnc #CTSM
How much progress have we made in targeting KRAS in GI malignancies?
Benedikt Westphalen, MD, Ludwig-Maximilians-University (LMU) Hospital, Munich, Germany, discusses advances in targeting KRAS. ...
ow.ly
ESMO 2022
🚨 24 hours until #ESMOAsia23 🚨
Make sure to stay tuned for the congress – follow us @VJOncology and head to http://VJOncology.com for exciting developments
@myESMO #Oncology #ImmunoOnc
🎥Jolanta Kunikowska of @UniWarszawski discusses the importance of genotype in accurate diagnosis and treatment of paragangliomas/pheochromocytomas:
➡️⬅️
@myESMO #ESMO23 #hncSM
The importance of genotype in accurate diagnosis and treatment of paragangliomas/ pheochromocytomas
Jolanta Kunikowska, MD, PhD, Medical University of Warsaw, Warsaw, Poland, discusses the observation of genotype in th...
ow.ly
November is #LungCancer Awareness month 🫁 📣
Check out this NEW VJSessions episode: #CTscreening for patients with #lungcancer in the UK with @BTOGORG 💬 🇬🇧
With David Baldwin, Beth Sage, Phillip Crosbie, Matthew Callister and Arjun Nair ⬇️
https://ow.ly/yozx50Q5n7H
#LCsm
🎥@RobinL_Jones from @ICR_London shares his highlights in sarcoma from #ESMO23:
➡️⬅️
@myESMO #scmSM
Highlights in sarcoma at ESMO 2023
Robin L. Jones, MBBS, MRCP, MD, Institute of Cancer Research in London, highlights key sessions in sarcoma at the ...
ow.ly
🎥@BenWestphalen of @LMU_Muenchen highlights the transformative impact of KRAS inhibitors, like sotorasib and panitumumab, across oncology, with significant advancements discussed at #ESMO23:
➡️⬅️
#PancSM #CRCSM #ImmunoOnc #CTSM
How much progress have we made in targeting KRAS in GI malignancies?
Benedikt Westphalen, MD, Ludwig-Maximilians-University (LMU) Hospital, Munich, Germany, discusses advances in targeting KRAS. ...
ow.ly
Latest videos from ESMO 2022!
View all
GU at ESMO 2022!
View all
GI at ESMO 2022!
View all
Breast cancer at ESMO 2022!
View all
Stay tuned for interviews with the following doctors and more...
